OneMedNet Corporation
ONMD · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.04 | -0.00 | -0.38 | -19.28 |
| FCF Yield | -18.42% | -84.26% | -1.97% | -0.64% |
| EV / EBITDA | -4.71 | -0.32 | -56.00 | -108.91 |
| Quality | ||||
| ROIC | 142.58% | 82.81% | -11,684.53% | 523.17% |
| Gross Margin | -43.70% | -12.63% | -31.29% | -10.39% |
| Cash Conversion Ratio | 0.69 | 0.14 | 0.15 | 0.63 |
| Growth | ||||
| Revenue 3-Year CAGR | -17.69% | -2.21% | 11.85% | 1,029,601.42% |
| Free Cash Flow Growth | -45.48% | 19.00% | -218.45% | 11.80% |
| Safety | ||||
| Net Debt / EBITDA | -0.87 | -0.15 | -1.75 | -1.54 |
| Interest Coverage | -65.34 | -623.00 | -15.28 | -13.87 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 10,352,451,731,324,928.00 |
| Cash Conversion Cycle | -2,395.77 | -1,431.69 | -672.79 | 30.67 |